Copyright 2001 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2001
A recent original investigation1 hints at a possible benefit of combining 2 drugs for the treatment of asthma. The study was sponsored by a pharmaceutical company, and 5 of the 8 authors were employed by that company. One of the drugs under investigation was manufactured by that company, and the generic and trade name were given; it was also called potent. The other drug manufactured by another company received no such accolade and was only mentioned by its generic name. It is difficult to assume an oversight.
Pierach CA. Drug Combination for Asthma Treatment. Arch Intern Med. 2001;161(15):1920. doi:
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: